The Latest Breaking News from J&J

Here's a roundup of top developments in the biotech space over the last 24 hours.

Company tested ingredients on Black inmates for years near Philadelphia, documents show

Review finds those who have received two doses of Pfizer/BioNTech, AstraZeneca or Moderna vaccine, or one dose of single-shot J&J vaccine, half as likely to develop long Covid symptoms

The controversial Johnson & Johnson bankruptcy strategy that’s drawn the ire of Congress faces a fresh trial this week, with the consumer products giant arguing that settling billions of dollars of talc liabilities in a single case is better for cancer victims than fighting thousands of individual claims.

Move to hold shareholder vote follows withdrawal of product in US and Canada and lawsuits alleging link to cancer cases

SAN FRANCISCO — San Francisco health officials are allowing people who originally got the Johnson & Johnson COVID-19 vaccine to get a second booster shot — which would give them access to the same number of doses currently available to recipients of Pfizer-BioNTech or Moderna.

Here's a roundup of top developments in the biotech space over the last 24 hours:

Here's a roundup of top developments in the biotech space over the last 24 hours.